• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

角膜炎的临床特征和治疗结果。

Clinical profile and treatment outcomes of keratitis.

机构信息

Department of Cornea and Anterior Segment Services, C L Gupta Eye Institute, Moradabad, Uttar Pradesh, India.

Department of Clinical and Public Health Research, C L Gupta Eye Institute, Moradabad, Uttar Pradesh, India.

出版信息

Indian J Ophthalmol. 2022 Mar;70(3):852-859. doi: 10.4103/ijo.IJO_999_21.

DOI:10.4103/ijo.IJO_999_21
PMID:35225530
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9114586/
Abstract

PURPOSE

To determine the seasonality, clinical profile, and treatment outcome of Fusarium keratitis.

METHODS

A retrospective medical chart review of 97 patients with culture-proven Fusarium keratitis at a tertiary eye care institution from January 2018 to December 2019.

RESULTS

The median (SD) age at enrollment was 44.6 (16) years; 75 (79.8%) of them were male. Presence of infiltrate less than 4 mm at baseline indicated 4.4 times the odds of achieving final BCVA more than 20/60 (95% CI: 1.4-13.3; P=0.008). The absence of surgical management indicated 8.1 times the odds of achieving final BCVA of more than 20/60 (95% CI: 0.9-71.5; P = 0.06). The visual acuity at presentation, duration between symptoms and presentation, history of ocular trauma, previous use of topical medications, and presence of hypopyon were not identified as significant predictors of final BCVA in the multivariable regression analysis.

CONCLUSION

Smaller infiltrate size and absence of surgical management are the significant predictors of good visual outcome. Visual outcome of Fusarium keratitis is poor, and a significant number of patients did not respond to anti-fungal therapy and had to undergo surgeries. To the best of our knowledge, this is the largest case series on Fusarium keratitis to date.

摘要

目的

确定镰刀菌角膜炎的季节性、临床特征和治疗结果。

方法

对 2018 年 1 月至 2019 年 12 月在一家三级眼科医疗机构进行的 97 例经培养证实为镰刀菌角膜炎患者的病历进行回顾性医学图表审查。

结果

入组时的中位(SD)年龄为 44.6(16)岁;其中 75 人(79.8%)为男性。基线时浸润小于 4mm 表明最终视力优于 20/60 的可能性增加 4.4 倍(95%CI:1.4-13.3;P=0.008)。没有手术治疗表明最终视力优于 20/60 的可能性增加 8.1 倍(95%CI:0.9-71.5;P=0.06)。多变量回归分析并未发现就诊时视力、症状出现至就诊时间、眼部外伤史、局部用药史和前房积脓等因素是最终视力的显著预测因素。

结论

较小的浸润面积和无手术治疗是良好视力结果的显著预测因素。镰刀菌角膜炎的预后较差,相当数量的患者对抗真菌治疗无反应,不得不进行手术。据我们所知,这是迄今为止关于镰刀菌角膜炎的最大病例系列。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d69/9114586/7b5cbc8ae9e1/IJO-70-852-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d69/9114586/dcaa8d95fbe9/IJO-70-852-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d69/9114586/7b5cbc8ae9e1/IJO-70-852-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d69/9114586/dcaa8d95fbe9/IJO-70-852-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d69/9114586/7b5cbc8ae9e1/IJO-70-852-g002.jpg

相似文献

1
Clinical profile and treatment outcomes of keratitis.角膜炎的临床特征和治疗结果。
Indian J Ophthalmol. 2022 Mar;70(3):852-859. doi: 10.4103/ijo.IJO_999_21.
2
Adjunctive Oral Voriconazole Treatment of Fusarium Keratitis: A Secondary Analysis From the Mycotic Ulcer Treatment Trial II.伏立康唑口服辅助治疗镰刀菌角膜炎:真菌性溃疡治疗试验II的二次分析
JAMA Ophthalmol. 2017 Jun 1;135(6):520-525. doi: 10.1001/jamaophthalmol.2017.0616.
3
Epidemiology and Clinical Management of keratitis in the Netherlands, 2005-2016.2005 - 2016年荷兰角膜炎的流行病学与临床管理
Front Cell Infect Microbiol. 2020 Apr 3;10:133. doi: 10.3389/fcimb.2020.00133. eCollection 2020.
4
Clinical characteristics, predisposing factors, and treatment outcome of keratitis.角膜炎的临床特征、诱发因素和治疗结果。
Indian J Ophthalmol. 2020 Oct;68(10):2088-2093. doi: 10.4103/ijo.IJO_90_20.
5
Contact-Lens-Associated Purpureocillium Keratitis: Risk Factors, Microbiologic Characteristics, Clinical Course, and Outcomes.隐形眼镜相关性青霉角膜炎:危险因素、微生物学特征、临床病程及转归
Semin Ophthalmol. 2017;32(2):157-162. doi: 10.3109/08820538.2015.1011342. Epub 2015 Feb 27.
6
Fusarium keratitis at a tertiary eye care centre in India.印度一家三级眼科护理中心的镰刀菌性角膜炎
Int Ophthalmol. 2015 Jun;35(3):387-93. doi: 10.1007/s10792-014-9961-5. Epub 2014 Jun 15.
7
The clinical and microbiological features and outcomes of fungal keratitis over 9 years in Sydney, Australia.澳大利亚悉尼地区 9 年真菌性角膜炎的临床和微生物学特征及转归。
Mycoses. 2020 Jan;63(1):43-51. doi: 10.1111/myc.13009. Epub 2019 Oct 27.
8
Comparison of culture-negative and culture-positive microbial keratitis: cause of culture negativity, clinical features and final outcome.培养阴性与培养阳性微生物性角膜炎的比较:培养阴性的原因、临床特征及最终结局
Br J Ophthalmol. 2015 Nov;99(11):1498-502. doi: 10.1136/bjophthalmol-2014-306414. Epub 2015 Apr 24.
9
[A 25-year-old patient with corneal infiltration].[一名25岁的角膜浸润患者]
Ophthalmologe. 2011 May;108(5):463-6. doi: 10.1007/s00347-010-2317-2.
10
Factors affecting treatment outcomes with voriconazole in cases with fungal keratitis.影响伏立康唑治疗真菌性角膜炎疗效的因素。
Cornea. 2013 Apr;32(4):445-9. doi: 10.1097/ICO.0b013e318254a41b.

引用本文的文献

1
Antifungal susceptibility and clinical efficacy of chlorhexidine combined with topical ophthalmic medications against species isolated from corneal samples.洗必泰联合局部眼科用药对从角膜样本中分离出的菌株的抗真菌药敏性及临床疗效
Front Cell Infect Microbiol. 2025 Apr 15;15:1532289. doi: 10.3389/fcimb.2025.1532289. eCollection 2025.
2
Treatment Strategies for Filamentous Fungi Keratitis.丝状真菌角膜炎的治疗策略。
Adv Ther. 2024 Aug;41(8):3316-3327. doi: 10.1007/s12325-024-02929-3. Epub 2024 Jul 3.
3
Fusarioid keratitis and other superficial infections: A 10-years prospective study from Northeastern Brazil.

本文引用的文献

1
Clinical characteristics, predisposing factors, and treatment outcome of keratitis.角膜炎的临床特征、诱发因素和治疗结果。
Indian J Ophthalmol. 2020 Oct;68(10):2088-2093. doi: 10.4103/ijo.IJO_90_20.
2
Clinical analysis of microbiologically proven fungal keratitis according to prior topical steroid use: a retrospective study in South Korea.根据既往局部使用皮质类固醇的情况对微生物学证实的真菌性角膜炎进行临床分析:韩国的一项回顾性研究。
BMC Ophthalmol. 2019 Oct 16;19(1):207. doi: 10.1186/s12886-019-1212-0.
3
Causative fungi and treatment outcome of dematiaceous fungal keratitis in North India.
类镰刀菌角膜炎及其他浅部感染:来自巴西东北部的一项 10 年前瞻性研究。
PLoS Negl Trop Dis. 2024 Jun 17;18(6):e0012247. doi: 10.1371/journal.pntd.0012247. eCollection 2024 Jun.
4
Identification of hub genes and pathways of ferroptosis in keratitis by bioinformatics methods.生物信息学方法鉴定角膜炎中铁死亡相关的枢纽基因和通路。
Front Cell Infect Microbiol. 2023 Jan 31;13:1103471. doi: 10.3389/fcimb.2023.1103471. eCollection 2023.
印度北部暗色丝孢霉角膜炎的病原菌和治疗结果。
Indian J Ophthalmol. 2019 Jul;67(7):1048-1053. doi: 10.4103/ijo.IJO_1612_18.
4
Delay Along the Care Seeking Journey of Patients with Microbial Keratitis in Uganda.乌干达微生物性角膜炎患者在寻求医疗过程中的延误情况。
Ophthalmic Epidemiol. 2019 Oct;26(5):311-320. doi: 10.1080/09286586.2019.1616775. Epub 2019 May 15.
5
Spectrum of mycotic keratitis in north India: Sixteen years study from a tertiary care ophthalmic centre.印度北部真菌性角膜炎的范围:来自一家三级眼科护理中心的十六年研究。
J Infect Public Health. 2019 May-Jun;12(3):367-371. doi: 10.1016/j.jiph.2018.12.005. Epub 2018 Dec 29.
6
The persistent dilemma of microbial keratitis: Global burden, diagnosis, and antimicrobial resistance.微生物角膜炎的持续困境:全球负担、诊断和抗菌药物耐药性。
Surv Ophthalmol. 2019 May-Jun;64(3):255-271. doi: 10.1016/j.survophthal.2018.12.003. Epub 2018 Dec 24.
7
Management Algorithm for Fungal Keratitis: The TST (Topical, Systemic, and Targeted Therapy) Protocol.真菌性角膜炎的管理算法:TST(局部、全身和靶向治疗)方案。
Cornea. 2019 Feb;38(2):141-145. doi: 10.1097/ICO.0000000000001781.
8
Fungal keratitis: The Aravind experience.真菌性角膜炎:阿拉文医院的经验
Indian J Ophthalmol. 2017 Oct;65(10):912-919. doi: 10.4103/ijo.IJO_821_17.
9
Fusarium Keratitis in Germany.德国镰刀菌角膜炎。
J Clin Microbiol. 2017 Oct;55(10):2983-2995. doi: 10.1128/JCM.00649-17. Epub 2017 Jul 26.
10
Scedosporium Keratitis: An Experience From a Tertiary Eye Hospital in South India.帚霉属角膜炎:来自印度南部一家三级眼科医院的经验
Cornea. 2016 Dec;35(12):1575-1577. doi: 10.1097/ICO.0000000000000969.